CA Healthcare Acquisition Corp. (NASDAQ:CAHC) announced in a press release today that its shareholders approved its combination with medical device-maker LumiraDx at a shareholder vote held earlier today.
Although the press release did not disclose information on its redemptions, CAHC traded above $10 throughout its redemption deadline September 24.
The combined company will begin trading on Nasdaq on September 29, under the ticker symbol “LMDX” for the common shares and “LMDXW” for the warrants assumed by LumiraDx from CAHC.
CH Healthcare originally announced its $5 billion combination with LumiraDx on April 7, but on August 20, CA Healthcare slashed the valuation by 40% from $5 billion to $3 billion due to “the recent market environment for publicly traded diagnostic companies, general market declines in COVID-19 testing volumes, and feedback from CA Healthcare advisors and shareholders.”
LumiraDx has developed a pair of diagnostic systems designed to decentralize testing for a range of conditions including COVID-19. Its platform is being used by the CVS (NYSE:CVS) network in the US and Boots pharmacies in the UK.
ADVISORS
- Evercore, Inc. and Raymond James & Associates, Inc. are serving as financial advisors to LumiraDx
- BTIG, LLC is serving as financial advisor and capital markets advisor to CA Healthcare Acquisition Corp
- Fried, Frank, Harris, Shriver & Jacobson LLP and Goodwin Procter LLP are serving as legal advisors to LumiraDx
- Sidley Austin LLP is serving as legal advisor to CA Healthcare Acquisition Corp
This week, we speak with Kyivstar CEO Oleksandr Komarov about the company’s $2.2 billion dollar combination with Cohen Circle Acquisition Corp. I (NASDAQ:CCIR). Few companies have been had to forge themselves in the flames recently quite like Ukraine’s leading telecom and digital services provider Kyivstar. Now, Kyivstar is not only telling that story but pitching it to...
At the SPAC of Dawn The market still has one full trading session before it adds Tuesday’s Core CPI reading and a variety of Fed comments to messaging it is already ingesting on US President Donald Trump’s ever-shifting tariff policy. SPACs are meanwhile continuing on with business as usual, with Cayson (NASDAQ:CAPN) announcing the third...
Terms Tracker for the Week Ending July 11, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. One more IPO priced this week bringing July’s total to 8. However, there are still three more weeks left in the month so that number...
At the SPAC of Dawn Lately de-SPACs have been announcing corporate moves of a kind frequently in trios as was the case earlier this week when WeBull (NASDAQ:BULL), AST SpaceMobile (NASDAQ:ASTS) and Quantum-Si (NASDAQ:QSI) all announced major equity raises. This week, it is a trio of de-SPACs making reverse stock splits in unison, which is...
A look at Plus’ software-first approach to autonomous trucking. After years of investment and excitement, the dawn of self-driving cars and trucks is now here. The question now is which business model among autonomous driving technology companies will win out? This week, we speak with David Liu, CEO of autonomous trucking company Plus. Plus announced...